ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly capital expenditures (additions to property and equipment, $M) ($M)
Form 10-Q / 10-K Consolidated Statements of Cash Flows & Segment Note
Latest, FY2025
7,841
Period ended Dec 31, 2025
Change on a year earlier
+55.0%
5,058 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Capital expenditures (additions to property and equipment, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,841 | +55.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 5,058 | +46.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 3,448 | +85.9% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 1,854 | +41.6% | Form 10-K (filed 2025-02-19) ↗ |
| FY2021 | Dec 31, 2021 | 1,310 | -5.6% | Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 1,388 | +34.2% | Form 10-K (filed 2023-02-22) ↗ |
| FY2019 | Dec 31, 2019 | 1,034 | -14.6% | Form 10-K (filed 2022-02-23) ↗ |
| FY2018 | Dec 31, 2018 | 1,211 | +12.4% | Form 10-K (filed 2021-02-17) ↗ |
| FY2017 | Dec 31, 2017 | 1,077 | +3.8% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 1,037 | – | Form 10-K (filed 2019-02-19) ↗ |
Cite this data
StockData. (2026). Eli Lilly Capital expenditures (additions to property and equipment, $M) ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/capex_additions
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.